{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4MHp9MoKDA","lastupdate":"2023-10-05T00:00:00.000Z","update_date":"2023-10-05T00:00:00.000Z","lastModified":"Aug 11, 2025","active":1,"confidence_score":99,"confidence_score_reason":"markets","urlname":"enzymit","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$6nkn9KpSVAMuDR8HUXMrrkaR177G6XY4GXJ3YxYoGK672oMcsAJMPc","name":"Enzymit","oneliner":"Cell-free Bioproduction","registrar":"516194693","website":"https://enzymit.com","careerspage":"","founded_month":6,"founded_year":2020,"formernames":[],"sociallinks":{"twitter":"https://twitter.com/enzymit","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/64880066","instagram":""},"social":["https://www.linkedin.com/company/64880066","https://twitter.com/enzymit"],"flattenedsociallinks":"https://www.linkedin.com/company/64880066|https://twitter.com/enzymit","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":22,"patent":1,"raised":17000000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","primary_sector":"Agriculture & Food Technologies","alternativenames":["enzymite"],"about":"Enzymit is a bioproduction platform company developing cell-free enzymatic manufacturing technology to make bioproduction faster, simpler, cost effective, and sustainable. The company's proprietary technology comprises complex computational design algorithms, deep-learning algorithms, and experimental tools to create novel enzymes.","climatetech_description":"Enzymit aims to replace outdated, pollution-producing chemical manufacturing with green, cell-free enzymatic production methods efficiently and cost effectively.\n \nEnzymit produces super-stable enzymes that are rugged enough to be reused many times in production cycles, reducing greenhouse gas emissions and energy input. The company also reduces land utilization and capital costs by utilizing continuous bioreactors that provide significantly more output with a much smaller footprint than fermenters. Lastly, it provides higher product yields with less waste and emissions by not consuming part of the initial feedstock in the conversion process.","is_climatetech_relevant":1,"phone":"+972-504222987","country":null,"address":{"israeli":[{"id":"lNn2XKSz4QrLpl6aAGJ9XaaMSk2HBWQ0AM0g4kxnIiUtbRT4LbQ24J","city":"Rehovot","type":null,"address":"Prof. Menakhem Plaut St 4, Rehovot, Israel","placeid":"ChIJfw6VGuW2AhUR63C_FPJKi5o","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":[{"id":"JGAhoy5weuk6CEQ8ME70yH2nWFa8OvpIGXCA1yVbYZ1RMloIxK0fTy","city":"Wilmington","address":"Wilmington, DE 19805, USA","country":"United States","placeid":null},{"id":"St1RxUrrOUVXLYTQoCkwMZdy6S2oI8x96RqxOkzwZfd1x5Dxm4u7IS","city":"Rehovot","address":"Prof. Menakhem Plaut St 4, Rehovot, Israel","country":"Israel","placeid":"ChIJfw6VGuW2AhUR63C_FPJKi5o"}]},"headquarter_address":null,"district":"Center District","news":[{"id":"OjfJ7wpC4auFCSgotEildpdgJuMn1aw9B41T51pSfk4ZdDHT4HcCuU","date":"Jun 24, 2025","link":"https://www.nizo.com/news/nizo-and-enzymit-scale-enzyme-production/","source":"www.nizo.com","visible":1,"analysis":{"tags":"biomanufacturing","round":null,"company":"Enzymit","layoffs":null,"summary":"Enzymit, in partnership with NIZO, has successfully scaled up the production of novel enzymes using its proprietary cell-free manufacturing platform. This innovative technology allows for the creation of high-value biomolecules without the use of living cells, offering a sustainable alternative to traditional biomanufacturing methods. The collaboration marks a significant advancement in the industrialization of cell-free manufacturing, paving the way for broader adoption in various industries, including pharmaceuticals and cosmetics. The partnership leverages NIZOs expertise in protein expression and fermentation technologies and Enzymits cutting-edge enzyme design capabilities, showcasing a new, more efficient, and environmentally responsible approach to biomanufacturing.","partners":["NIZO"],"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["bioproduction","enzymes","sustainability","collaboration","innovation"],"date_of_event":"June 24, 2025","product_stage":"pilot","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"LN506m1Yz1p5N1UGW6boI05pcAZriBQxblUm7N8kQkjY0ofcnE9E6J","news_summary":"NIZO and Enzymit Joined Forces to Successfully Scale Enzyme Production | NIZO","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"qyRpGM5d9qUkZ6B22cTbmRKZTAQ8TLFvObou12MZbPDho6OcJ6v3pR","date":"Apr 25, 2025","link":"https://theinnovator.news/startup-of-the-week-enzymit/","source":"theinnovator.news","visible":1,"analysis":{"tags":"bio-manufacturing","round":null,"company":"Enzymit","layoffs":null,"summary":"Enzymit, an Israeli company recognized as a 2024 World Economic Forum Technology Pioneer, is advancing a cell-free bio-production technology aimed at transforming global manufacturing. By leveraging computational design and deep learning, Enzymit is engineering enzymes with enhanced stability and efficiency, offering a greener alternative to traditional chemical manufacturing. The company has raised $15 million and is collaborating with global partners to validate its synthetic hyaluronic acid for cosmetic and medical applications. Enzymits technology promises significant reductions in energy and water usage, supporting sustainable and localized production. The company is currently in the pilot stage, with plans to scale up production and expand into various markets.","partners":"L’Oreal, Estee Lauder","customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["bio-production","AI technology","enzyme engineering","sustainability","supply chain"],"date_of_event":null,"product_stage":"pilot","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Product Stage","Partners","Investment"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Product Stage  #Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"4vuyQeH90TT5LHEXYej3yBCRT41aaUuqWbJyCkAXtpvFwVP6m5cKG9","news_summary":"Startup Of The Week: Enzymit - The Innovator","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"kaR6CvwDaMjjVl95V2ksM55jMmxSF9ODB4aVrPGoSn9pdmnX8KHlfR","date":"Sep 25, 2024","link":"https://www.calcalistech.com/ctechnews/article/b1k3mjxrr","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Series A funding","company":"Enzymit","layoffs":null,"summary":"Enzymit, an Israeli synthetic biology startup, has secured $10 million in a Series A funding round led by Grove Ventures and Khosla Ventures, with participation from First Star Ventures and Sapir Venture Partners. Founded in 2020, Enzymit is developing a cell-free production platform designed to make bioproduction faster, simpler, cost-effective, and scalable. The company uses computational design and deep learning to create novel enzymes optimized for cell-free systems, aiming to revolutionize bio-production. The funding will help establish a pilot facility and scale production for global distribution.","partners":null,"customers":null,"investors":["Grove Ventures","Khosla Ventures","First Star Ventures","Sapir Venture Partners"],"confidence":10,"key_topics":["bioproduction","enzymes","funding","technology","scalability"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$10 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"8TJrkIEYwr5fZakeufXuZHqS0UgEb2Pq0YoBjfr8iPDFysahVpMO0G","news_summary":"Enzymit raises $10 million Series A for cell-free bio-production technology | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"iKWQjhjschBDfScGDLa7kAGOEwTHVHLwIDVUQCJVDLANwg9gecb6fi","date":"Jun 6, 2024","link":"https://www.weforum.org/agenda/2024/06/2024s-new-tech-pioneers-world-economic-forum/","source":"www.weforum.org","visible":1,"analysis":null,"sentiment":null,"analysisId":"BCb7VpWq6WItz2KegsdjvPVNAwT9oXGd6AYg94dBxDiuRh3VxOACbN","news_summary":"Meet the 2024 Technology Pioneers of the World Economic Forum ","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"REjQE67bkV7JiF9findo5V9utKiEJTuw8HhhqJseKjDDQeywdjp3nH","date":"Mar 24, 2024","link":"https://innovationisrael.org.il/en/article/materials-from-another-world/","source":"innovationisrael.org.il","visible":1,"analysis":null,"sentiment":null,"analysisId":"xTybGXmVtrgzI4SV3TLDDvJuKIyawrNN83JXeBZYrVA4c40ioIUzkq","news_summary":"Farsighted vision based on bio-convergence is driving two Israeli companies towards the development of innovative materials: Seevix has developed a fiber inspired by spiderwebs – the ‘Holy Grail’ of the world of materials – while Enzymit designs and builds enzymes, biological nanomachines capable of creating any material.","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"L1mzXKhUGWwfmnik1cs5ig1Bijm7wrjaoB0TCHcAwS7rLbod66ahsf","date":"Sep 27, 2023","link":"https://www.thetimes.co.uk/article/glow-in-the-dark-bacteria-could-detect-millions-of-landmines-9ptb79r3d","source":"www.thetimes.co.uk","visible":1,"analysis":{"tags":"Biotechnology, Innovation","company":"Enzymit","layoffs":"Not mentioned","summary":"Enzymit, a biotechnology firm, is developing a safer method for detecting landmines by using bacteria. The companys CEO, Gideon Lapidoth, has partnered with a team at the Hebrew University of Jerusalem to engineer bacteria that glow in the presence of explosives. This innovative approach aims to reduce the risk to humans involved in landmine detection and removal.","partners":"Hebrew University of Jerusalem","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":"Biotechnology, Landmine Detection, Bacteria, Innovation, Partnership","date_of_event":"September 27, 2023","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Partners","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5Cix73P8JMpB9ffhdl3aCnCZdgGrujIn24VrgvYjOObF7D62WvVlOH","news_summary":"Glow-in-the-dark bacteria could detect millions of landmines","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"QzdfuI1e5mmKPhisUkNTTTcayAwNEa3StOJsyUTR2xAWgMcT94zJ8c","date":"Sep 24, 2023","link":"https://espresso.economist.com/b76f4e72625e1782dd4758a45cbc1cd6","source":"espresso.economist.com","visible":1,"analysis":null,"sentiment":null,"analysisId":"mAJbUZcMzLAPGm5tnppqeckPDazKVAkYqJNHvzRJ99uqfSElZjK6jN","news_summary":"Using bacteria to detect mines","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"none"},{"id":"5S1Umwn7MpqT76No4DWpWAKxrm9bdFpKbUCUYGIADyHJn6IfxjA2n9","date":"Sep 19, 2023","link":"https://www.prnewswire.com/news-releases/breakthrough-in-landmine-detection-enzymit-enabled-tnt-biosensor-developed-in-collaboration-with-hebrew-university-301930819.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"Partnership, Technology Development","company":"Enzymit","layoffs":"Not mentioned","summary":"Enzymit, a bioproduction platform company, has announced a breakthrough in landmine detection through the development of a protein-based biosensor. The company collaborated with researchers from the Hebrew University of Jerusalem to create a biosensing platform that can detect trace amounts of dinitrotoluene (DNT), a byproduct of TNT that leaks out of mines. The sensor is up to five times more sensitive and has a signal strength 30 times stronger than the original construct. The teams are currently working to further optimize the system and explore how the platform can be expanded to detect other hazardous materials.","partners":"Hebrew University of Jerusalem","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":["Landmine Detection","Biosensor","AI","Deep Learning","Partnership"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Partners","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"8jb2O6aeOndeh4u6MYnUK0lK9PTniGqarffFNO77Np9WWIxWW6uSrS","news_summary":"Breakthrough in Landmine Detection: Enzymit-Enabled TNT Biosensor Developed in Collaboration with Hebrew University","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ncUSim70RD9VUXQu4gN7FJNCKxlZEwdcJ8pJ4Z0MMw3Om5BpxAs0Iy","date":"Aug 24, 2023","link":"https://www.synbiobeta.com/read/where-infant-formula-falls-short-synthetic-biology-comes-up-strong","source":"www.synbiobeta.com","visible":1,"analysis":{"tags":"Healthcare, Biotechnology","company":"Enzymit","layoffs":"Not mentioned","summary":"Enzymit, an emerging enzyme engineering company, is using artificial intelligence to design enzymes that can produce human milk oligosaccharides (HMOs) more efficiently and at a lower cost. HMOs are critical for the development of an infants microbiome and are found in high concentrations in breast milk. However, they are difficult and expensive to produce for use in infant formula. Enzymits AI-based platform can predict enzyme structures that will perform known or novel functions, potentially reducing the cost of HMOs by 50%. This could lead to more affordable and nutritionally complete infant formulas.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":"Enzyme Engineering, Infant Nutrition, Artificial Intelligence, Microbiome, Breast Milk","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"faAx5jgtbEOL7NlMWfliUEz7P65mvgcHzw2FOVCifSJ5tnuEpDZZfl","news_summary":"Where Infant Formula Falls Short Synthetic Biology Comes Up Strong - SynBioBeta","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"hzNqwM6wjdeqyPm7p0hkLPnZGfjVGIZdhl4IBrrG4lwoSS7O8WUbFR","date":"Aug 21, 2023","link":"https://www.prnewswire.com/news-releases/new-research-demonstrates-application-of-enzymits-deep-learning-technology-for-novel-biocatalysis-design-301905438.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"AI, enzyme design, cell-free bioproduction","company":"Enzymit","layoffs":null,"summary":"Enzymit, a specialty biochemical company, has published a study demonstrating the efficacy of its deep learning-based technology for novel enzyme design. The study proposes an alternative approach to enzyme design by modifying existing enzymes to work with new molecules under different conditions. Enzymit developed two AI-based tools, CoSaNN and SolvIT, which enabled the creation of new enzymes with higher thermal stability and superior expression levels. The research highlights the transformative potential of AI in enzyme sequence design and its ability to create stable enzymes for a wide range of commercial applications. Enzymit is building a cell-free production platform to make bioproduction faster, simpler, cost-effective, and sustainable.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["AI-based tools","enzyme design","cell-free bioproduction","deep learning","novel enzymes"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"92Tfpa32EvutXu21MoIxjqmFWMxOTWR1IJoSNnTwDqMq1JDapUnKkd","news_summary":"New Research Demonstrates Application of Enzymit's Deep Learning Technology for Novel Biocatalysis Design","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"ySRFJ8vFmWcMZdlnfM1Xetuf72A5Pdqcq4bftEfoQHlWl9Ck1tHt0e","date":"Aug 21, 2023","link":"https://www.opp.today/news2/new-research-demonstrates-application-of-enzymits-deep-learning-technology-for-novel-biocatalysis-design/18300/","source":"www.opp.today","visible":1,"analysis":{"tags":"AI, Enzyme Design","company":"Enzymit","layoffs":"Not mentioned","summary":"Biochemical company Enzymit has published a study demonstrating the effectiveness of its deep learning-based technology for novel enzyme design. The company has developed two AI-based tools, CoSaNN and SolvIT, for this purpose. CoSaNN uses deep learning to generate new enzyme conformations, enabling the redesigning of enzymes and new chemical reactions. SolvIT is a predictive model for protein solubility in E. coli, providing an additional layer of optimization for producing highly expressed enzymes. Using these tools, Enzymit created new enzymes with higher thermal stability and superior expression levels. The research highlights the potential of AI in enzyme sequence design.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":9,"key_topics":"Deep Learning, Enzyme Design, Protein Solubility, Thermal Stability, Bioproduction","date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7TBkjh67BiX9Lajg9coRUndBsZfISp9Uipw3OoCs7TFwcA8zAJzGEy","news_summary":"Study Reveals Potential for New AI-Based Tools to Transform Enzyme Design, Catalyzing Cell-Free Bioproduction Across Multiple Industries","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"AmHqG3ct0gMbjBRdE1F0QktjMLnZASucpNbhptYxf4qrQuNJri4Fc4","date":"Aug 21, 2023","link":"https://aithority.com/technology/new-research-demonstrates-application-of-enzymits-deep-learning-technology-for-novel-biocatalysis-design/","source":"aithority.com","visible":1,"analysis":{"tags":"AI, Enzyme Design","company":"Enzymit","layoffs":"Not mentioned","summary":"Biochemical company Enzymit has announced the publication of a study demonstrating the effectiveness of its deep learning-based technology for novel enzyme design. The study proposes a new approach to enzyme design by modifying existing enzymes to work with new molecules under different conditions. This was achieved through the development of two new proprietary AI-based tools, CoSaNN and SolvIT. The tools enabled the creation of new enzymes with significantly higher thermal stability and superior expression levels compared to alternative methods.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":["AI-Based Tools","Enzyme Design","Cell-Free Bioproduction","Deep Learning","Protein Solubility"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Investment","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"stvPq9s4Gplx50xVcQLCDleIaQkNWusZVNvhVoHc7zlHdxa1bdOx5a","news_summary":"New Research Demonstrates Application of Enzymit's Deep Learning Technology for Novel Biocatalysis Design","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"QMxN7eqIzqEFSeaKflvHSIAK2NYCmHcTbwgg4San3UZETM6XcDXoCI","date":"Aug 11, 2023","link":"https://www.cosmeticsdesign-europe.com/Article/2023/08/11/5-exciting-new-developments-in-cosmetic-science","source":"www.cosmeticsdesign-europe.com","visible":1,"analysis":{"tags":"synthetic biology, enzymatic process","company":"Enzymit","layoffs":null,"summary":"Enzymit, a synthetic biology company, has developed an enzymatic process to create cell-free hyaluronic acid (HA) for cosmetics companies. The company claims that this process will reduce costs by up to 50% compared to traditional fermentation methods. Enzymits expertise in computational enzyme design and carbohydrate synthesis allowed them to achieve enzymatic bioproduction of HA with tailored molecular weights. The cell-free approach eliminates the need for complex downstream processing and enables more efficient production at scale. The article also mentions other developments in the beauty industry, such as Cambriums validated vegan collagen, Mixer & Packs RFID technology for fragrance production, snow fungus as an alternative to HA, and Kaffe Buenos coffee-based SPF booster.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["cell-free hyaluronic acid","cost reduction","enzyme design","specialty chemicals","cosmetics industry"],"date_of_event":"Not specified","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"XSU6Jc3AWpHKttpCKkqmlxPONQBuQPyfTsChd7rzsT8yZ1qx7RW6pb","news_summary":"5 exciting new developments in cosmetic science","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"nggmj2sdCGCvulK3qQXLI91WBEOdGvI3AvdKbkGAJBlGjcXAB0nqwF","date":"Aug 1, 2023","link":"https://www.i24news.tv/en/news/israel/technology-science/1690889148-israeli-startup-enzymit-achieves-breakthrough-in-hyaluronic-acid-production","source":"www.i24news.tv","visible":1,"analysis":{"tags":"Biochemical Production, Cost Reduction","company":"Enzymit","layoffs":"Not mentioned","summary":"Biochemical company Enzymit has announced its success in synthetically producing hyaluronic acid (HA) for use in cosmetic, aesthetic, and therapeutic applications using cell-free enzymatic manufacturing technology. This process reduces the complexity, time, and costs traditionally associated with HA production. The companys CEO, Gideon Lapidoth, stated that their cell-free approach significantly reduces overall costs and enables easier and more efficient production at scale. Enzymit is receiving interest from manufacturers looking to incorporate their HA variants into skincare products and is working to increase its production capacity.","partners":"Not mentioned","customers":"Not mentioned","investors":"Not mentioned","confidence":8,"key_topics":["Hyaluronic Acid","Enzymatic Manufacturing","Cost Reduction","Production Expansion","Strategic Partnerships"],"date_of_event":"Not mentioned","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":["Customers","Partners","Expand"],"acquisition_amount":"Not mentioned","structuredIssuesShow":"#Customers  #Partners  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"mdptBcJ10ZcV4sKiikj9HliqM419NXDssun9UnKypMhKsK3S3kC9Nv","news_summary":"Israeli startup Enzymit achieves breakthrough in hyaluronic acid production - I24NEWS","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5ePJqaza6lcJcwslnEWFi2WYlqACbKiSuAPWXGXALlQXpedletlihO","date":"Jul 4, 2023","link":"https://www.technologynetworks.com/tn/blog/you-have-no-moat-the-great-ai-democratization-spells-new-challenges-and-opportunities-for-synbio-375607","source":"www.technologynetworks.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"salBxcnqBxFaQKvnxQtAEuvuhHwP3hyOQebGdjHqpasEE8kcp79A6Y","news_summary":"You Have No Moat - The Great AI Democratization Spells New Challenges and Opportunities for SynBio Companies","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"fOK01MJfj99zyVAbzcx3Oq4CAaxCd0ysnV1kDuXzHhZ4oQUXqyKjgv","date":"May 16, 2023","link":"https://www.prnewswire.com/il/news-releases/enzymit-partners-with-aleph-farms-to-reduce-production-costs-and-shorten-time-to-market-for-cultivated-meat-301825570.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"bioproduction, enzymatic manufacturing, cultivated meat, insulin substituents","company":"Enzymit","layoffs":null,"summary":"Enzymit has successfully developed insulin substituents in partnership with Aleph Farms, which can reduce the cost and development time for producing cultivated meat at scale. The collaboration aims to create more suitable processing aids for the production of cultivated meat, driving economies of scale and cost-efficiency. The development of novel insulin substituents opens the door to benefits beyond cow cells, potentially influencing the production of other cultivated meat types. Enzymit utilized its computational design algorithms and testing capabilities to quickly develop a variety of insulin substituents, resulting in proteins that require fewer downstream purification and maturation processes, reducing production time and costs. Enzymit is a bioproduction platform company based in Israel, while Aleph Farms is a food technology company focused on sustainable animal product growth.","partners":"Aleph Farms","customers":null,"investors":null,"confidence":8,"key_topics":["AI","Deep Learning","Insulin Substituents","Cultivated Meat Production","Cost-Efficiency"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"wH2Zk7jAWFZ89v1kD2kHyvJDm46m9qc6tqjpf3yEjRrXht5oAwrJcQ","news_summary":"Enzymit Partners with Aleph Farms to Reduce Production Costs and Shorten Time-to-Market for Cultivated Meat","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"7j3j0nnsDjk5GEcKaGYgAkY9xvjzj46Iqm6Ey4aVZBVfAvy16n1OWG","date":"Apr 22, 2023","link":"https://www.jpost.com/opinion/article-739825","source":"www.jpost.com","visible":1,"analysis":{"tags":["plastics","environment","innovation"],"company":"Biotic Circular Technologies","layoffs":null,"summary":"The article discusses the issue of plastic waste and the need for alternatives. It highlights a recent event called Disrupting the Future of Plastics, where start-ups presented innovative solutions. Biotic Circular Technologies emerged as the winner with its fully bio-based, fully biodegradable plastic alternative made from organic materials. The company aims to replace fossil-based plastics and reduce costs by at least 50%. They are in the final stages of moving into a pilot facility to scale production volumes. The article emphasizes the importance of finding alternatives to plastics and mentions Israels innovation ecosystem as a key player in the future of plastics.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["plastics","biodegradable","alternative materials","innovation","environment"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6NJqkMKJVxmgqCA5raSGqnCOCJyn2e25B3hWGVcHlonbe5hzXjuyc4","news_summary":"How can Israel go plastics-free?","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"zuWntDTa5FCkhOFBC626n92LdzfPznK5YPBfxWn3px3potOAUBamMk","date":"Apr 16, 2023","link":"https://nocamels.com/2023/04/designing-the-enzymes-that-mother-nature-didnt/","source":"nocamels.com","visible":1,"analysis":{"tags":["enzyme design","fermentation","industrial processes"],"company":"Enzymit","layoffs":null,"summary":"Israeli startup Enzymit has developed computer algorithms to design enzymes for various industrial processes. The companys algorithms generate new enzyme sequences that can be used to create proteins with desired traits. Enzymit works with companies that print the DNA required for industrial production. The startup has already worked with a producer of hyaluronic acid and is currently developing enzymes for the production of prebiotics found in breast milk. Enzymit is also part of a consortium working on creating enzymes that can break down plastics. The companys technology has the potential to revolutionize various industries by simplifying and optimizing the production of chemicals and materials.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Enzymes","Synthetic insulin","Fermentation","Plastic degradation","Industrial processes"],"date_of_event":"1922","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"fqZRZoMoukmnwRJWiDVTdXP4sWPbADgMTFHPikOMdE3JvlI1D7JXYd","news_summary":"Designing The Enzymes That Mother Nature Didn't","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Pfw8we9DQNiofQ9JWvFukXadD4BglEzaSfPkKa77wcM9VDyI1g8Vo7","date":"Apr 1, 2023","link":"https://cen.acs.org/business/start-ups/Potential-thermochemistry-replacements-starred-Paris/101/i11","source":"cen.acs.org","visible":1,"analysis":{"tags":"Innovation, Competition","company":"Sweetch Energy","layoffs":"N/A","summary":"Hello Tomorrow’s Global Summit technology competition in Paris saw Sweetch Energy, a French start-up, win the €100,000 grand prize. The company generates emission-free energy using a nanoscale membrane that creates an electrical charge by exploiting the difference in salinity between river water and seawater. Other companies showcased included enaDyne, which uses nonthermal plasma catalysis to convert CO2 and a hydrogen source into chemicals and fuels, and New Iridium, which uses light-powered catalysts to make pharmaceuticals and other chemicals at low cost.","partners":"Boston Consulting Group","customers":"N/A","investors":"N/A","confidence":9,"key_topics":["Deep-tech startups","Innovation","Greenhouse gas emissions","Chemical processes","Energy generation"],"date_of_event":"March 2023","valuation_amount":"N/A","impact_on_company":"growth-positive","investment_amount":"€100,000","structured_issues":"Investment, Partners","acquisition_amount":"N/A","structuredIssuesShow":"#Investment, Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"CnQLVVzJ9UxlfaPPjvjsOvKiZTmk6HcNJ3GkA4h9SgKtBAZMu6yO07","news_summary":"Potential thermochemistry replacements starred at Paris conference","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"upCXxI70nsy1W9vV6lrWKeHJ3w5IxgXsm2BRRWX8WLHlydfpXzAyXB","date":"Feb 23, 2023","link":"https://www.prnewswire.com/il/news-releases/enzymit-receives-iso-9001-quality-management-system-certification-for-sustainable-enzyme-development-301751678.html","source":"www.prnewswire.com","visible":1,"analysis":{"tags":"ISO certification","company":"Enzymit","layoffs":null,"summary":"Enzymit, a bioproduction platform company, has been awarded ISO 9001:2015 certification for its design of novel enzymes and enzymatic processes. The certification demonstrates Enzymits commitment to quality management and customer satisfaction. Enzymit develops enzymes and enzymatic processes to make bioproduction faster, simpler, more cost-effective, and sustainable. The companys proprietary technology platform combines deep learning with computational design algorithms and high-throughput testing capabilities. Enzymit aims to serve a wide variety of markets and exceed customer expectations. The achievement of ISO 9001 certification is seen as a significant step towards realizing the goal of largescale cell-free bioproduction. Enzymit was founded in 2020 and is headquartered in Ness Ziona, Israel.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["ISO certification","Enzymatic processes","Quality Management System","Enzymits technology platform","ISO 9001"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pBrta9ce9egz84JCNychS57DYFeW7EVhkzKjfmykXebpyblRTL84eU","news_summary":"Enzymit Receives ISO 9001 Quality Management System Certification for Sustainable Enzyme Development","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"K9hwkMd8vbAdNFAUze9f8fO6jFhVUtPTqDIf7fd5UMCnCs5muOneQw","date":"Jan 30, 2023","link":"https://medika.life/covid-became-a-medtech-proving-ground-pointing-to-planetary-health-priorities/","source":"medika.life","visible":1,"analysis":{"tags":"health innovation","company":"Medika Life","layoffs":null,"summary":"The article discusses the growth and investment trends in the digital health sector, highlighting the importance of innovation and sustainability in addressing public health challenges. Medika Life plans to visit various health innovation hot spots around the world. Tel Aviv, Israel is mentioned as a leading hub for health tech and ecohealth. The article also mentions several Israeli companies worth watching in the health tech sector. Overall, the article has a positive impact on Medika Life as it focuses on growth opportunities and highlights the companys involvement in the health innovation space.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["Health innovation","Digital health","Investment","Synthetic biology","Israeli companies"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"C5b5KGIrncqrmenO6lRc3V3uwpwIeyb3X48qwdKRD6Unmu66LsKldC","news_summary":"Six Israeli Health Tech Companies Worth Watching","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"251158ef-abbc-4df4-82b0-4e943c333c33","date":"Apr 6, 2022","link":"https://www.einnews.com/pr_news/567725114/enzymit-inc-successfully-closes-5-million-seed-round-to-transform-the-global-chemical-market","source":"www.einnews.com","visible":1,"analysis":{"tags":["syn-bio production platform","seed round","computational design platform","product pipeline","enzymatic manufacturing","bio revolution","biomanufacturing industry","enzymes","organisms","cell-free process","novel enzymatic process","carbon conversion","global chemical market"],"company":"Enzymit Inc.","layoffs":null,"summary":"Enzymit Inc., a syn-bio production platform company, has closed a $5 million seed round led by First Star Ventures. The company plans to use the investment to accelerate the development of its computational design platform and expand its product pipeline. Enzymits platform is based on enzymatic manufacturing and aims to replace inefficient and polluting chemical reactions used in modern production methods. The company is developing new-to-nature enzymes that can catalyze new reactions and outperform existing enzymes. Enzymit is also working on a novel enzymatic process to convert carbon from the air to bio-polymers. The bio revolution holds promise, and Enzymit aims to significantly impact the biomanufacturing industry and the global chemical market.","partners":null,"customers":null,"investors":["First Star Ventures","Sapir Venture Partners"],"confidence":9,"key_topics":["Enzymit Inc.","seed round","computational design platform","product pipeline","enzymatic manufacturing"],"date_of_event":"April 6, 2022","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"nSuFCRMwZBfl8nMxaN7g9ezS1n1Ld8EUhnBByCs2QssJSbBubfyD2I","news_summary":"Enzymit Inc. Successfully Closes $5 Million Seed Round to Transform the Global Chemical Market","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"81c9076f-36fe-4b47-9acd-e24c31606c8c","date":"Nov 13, 2020","link":"https://insights.figlobal.com/startups/engineering-novel-enzymes-key-creating-healthier-food-interview","source":"insights.figlobal.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"p4yBA9AiUN6UCh9HBnkNYpgSedHQJV87BzglI3ntPulhZKSUdsofmQ","news_summary":"Engineering novel enzymes is key to creating healthier food [Interview]","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"Rf0aRG86q4onmj7xTfolfuXZFLMpbbfYsEZFRcQVo6eq50yARyfW7S","date":"Nov 4, 2020","link":"https://www.figlobal.com/fieurope/en/visit/news-and-updates/winners-innovation-awards-and-startup-innovation-challenge.html","source":"www.figlobal.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"HiiDL10lZV0yr4r87xQtcJPPR9VVEfqSslNPH4O5IquuvLblT4QVMv","news_summary":"Winners of Fi Europe Innovation Awards and Startup Innovation Challenge at Fi Europe CONNECT 2020","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":24,"techcommunityinvolvement":null,"mediagallery":[{"id":"nFmpMpXWF7zUjPgtRtL4yH3v3GWbtwBH4Wy5Js0RnpJGuBQQJ4Gpgt","timestamp":"2023-03-01 10:27:25.000000","resources_type":2,"resources_title":"Gideon Lapidoth (CEO/Co-Founder of Enzymit) joins the First Star Ventures team to discuss: why synthetic biology and bio-production are so critical for the future","resources_file_name":"ZRn-sxOxyCc","alt":"Gideon Lapidoth (CEO/Co-Founder of Enzymit) joins the First Star Ventures team to discuss: why synthetic biology and bio-production are so critical for the future logo","imageurl":"https://img.youtube.com/vi/ZRn-sxOxyCc/0.jpg","url":"http://youtu.be/ZRn-sxOxyCc"}],"tags":["biofuel","climate-tech","biomaterials","biotechnology","artificial-intelligence","deep-learning","food-and-beverage","machine-learning","proteins","biodegradable","plastics","pharma-companies","foodtech","cosmetic-companies"],"classificationIDs":["pmOn9QejBmHE4v4ME8eer1Fgn94EqGjX7Pcq1pHOxTziTLZFvyYD6P","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H","bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDl6YLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvtsb8KDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1usgLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"R&D","products":[],"geomarkets":[],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":8,"lastfunding":"$10M","totalrounds":5,"fundingstage":"A","totalfunding":"$17M","publicinvestors":8,"lastpublicfunding":10000000,"totalpublicrounds":4,"totalpublicfunding":16500000},"team":[{"name":"Gideon  Lapidoth","email":"gideon@enzymit.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4I7zoa8JDA","bounced":false,"claimed":1,"founder":1,"urlname":"gideon-lapidoth","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgkcTW8AgM","position":"Co-founder & CEO","last_name":"Lapidoth","claimtoken":"23e129fa3553ff70607161e5f933fdf403f1927045ba99f795a8a8906ccd1b9f","first_name":"Gideon ","picturekey":"$dcgvINgafDMj4E3NHFAfo135JsY0M4bhcL9mGu6Jj0H6zqXdVYRysQ","claimeddate":"2020-06-30","linkedinurl":"https://www.linkedin.com/in/gideon-lapidoth-94299035/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2020-06-30 13:19:14.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$dcgvINgafDMj4E3NHFAfo135JsY0M4bhcL9mGu6Jj0H6zqXdVYRysQ","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dror Baran","email":"dror@enzymit.com","phone":"972-504222987","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OHnzKcJDA","bounced":false,"claimed":1,"founder":1,"urlname":"dror-baran-1","visible":1,"memberid":"NOPBQoPOoG2LRL0L3guYZKe1iXetP663aWLwciKth2VV2XqpWCy2KS","position":"Co-founder & COO","last_name":"Baran","claimtoken":"xqwfyoZZ9bJy3gVa2YFuug61qwLXZC5Q0UNbWbIiocA2kS6Lh8MpRw","first_name":"Dror","picturekey":"$n8NWAwIE7M9nOMRNebWiVGwHcnK4BarCCV9N4I7jYSxkBw4AwLStxj.jpeg","claimeddate":"2023-02-01","linkedinurl":"https://www.linkedin.com/in/dror-baran/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2023-02-01 11:23:55.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$n8NWAwIE7M9nOMRNebWiVGwHcnK4BarCCV9N4I7jYSxkBw4AwLStxj.jpeg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dror Baran","email":"dror@enzymit.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4OHnzKcJDA","bounced":false,"claimed":1,"founder":null,"urlname":"dror-baran-1","visible":1,"memberid":"MpgIJT6pzOKBF3C8pzdw62lnAV3RHJpgPBguyYvaA7JkfA9L3rIsEW","position":"","last_name":"Baran","claimtoken":null,"first_name":"Dror","picturekey":null,"claimeddate":"2025-08-11","linkedinurl":"https://www.linkedin.com/in/dror-baran","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"DB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"AgriFood-tech & Water","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgKPMgJAKDA","fullname":"Shmuel (Sam) Rausnitz"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-06-30T00:00:00.000Z","crunchbaseid":"enzymit","lastupdator":"Ortal Wein","lastupdator_email":"ortalw@sncentral.org","creator":"Dror Baran","creator_email":"dror@enzymit.com","createdate":"2020-06-29T00:00:00.000Z","biverification":"Jenny Sotnik-Talisman","sectorverification":"Shmuel (Sam) Rausnitz","affiliatedOrganizations":null,"timeline":[{"id":"Nq69WHzwAQF0pvdmfoMx8DBsgdQOAphSObuytSEMpm1qENy9vTuqFi","date":"Sep 2024","amount":"$10M","source":"https://www.calcalistech.com/ctechnews/article/b1k3mjxrr //https://www.divedigital.de/projects/, PB","eventtype":"FundingRoundEvent","investment":[{"name":"Khosla Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d7jYNinoQTmjVGth3sW0jyrejGhDeW8xNtIL3kcnBpCWBKzUcmN7zF","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Grove Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/grove-ventures","logokey":"$n4AHC9JNL8UoAR7yguMpBlRFWXOp9AkDTErvx7uuoQcLXJ1dRsa5nb","tagline":null,"urlname":"/investor_page/grove-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwLioiJYKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"kXQPrVNeigj3WyQq1FPc58cX53098h3x1ayM7B7OQwtohYq2meyG8U","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$n4AHC9JNL8UoAR7yguMpBlRFWXOp9AkDTErvx7uuoQcLXJ1dRsa5nb","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"First Star Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/first-star-ventures","logokey":null,"tagline":"","urlname":"/investor_page/first-star-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJD04szaCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LEyutPLnD9efJADBV7CXk2avlxTuBOl9aZJM1T7rFPUU0aRQRXqulF","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Sapir Venture Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"q5I6SRLXeprnogtgbLhjvN2xvvRFlaGfO45THl42pjyVVVoRRL4V6t","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"DIVEdigital","type":"Investor","amount":null,"hidden":false,"country":"Germany","fullurl":"/investor_page/divedigital","logokey":"$YcNs5CAZ4k0qKPWbpYHUDkUsGkJ5sS35ElCQVDIAR2JmRA5AzUgYD7.png","tagline":"","urlname":"/investor_page/divedigital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP2jCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"xS1qnWHJex5myh4V8ruUXjx4YxzTS7PiyLxLHUTX6TVvUxlHipMSzX","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YcNs5CAZ4k0qKPWbpYHUDkUsGkJ5sS35ElCQVDIAR2JmRA5AzUgYD7.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"RvQn6HQjEHYBIOIoomjVeFa165iHExqX3FPvt0U4R8IcjxKGSBmsjw","date":"Nov 2022","amount":"$500K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDMxP_dCww","date":"Jan 2022","amount":"$5.5M","source":"https://www.einnews.com/pr_news/567725114/enzymit-inc-successfully-closes-5-million-seed-round-to-transform-the-global-chemical-market","eventtype":"FundingRoundEvent","investment":[{"name":"First Star Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/first-star-ventures","logokey":null,"tagline":"","urlname":"/investor_page/first-star-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJD04szaCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"YbjJ3TjDmxBhPHCjMkP2tj8E0W1B3veVKTa8OtU1trFJi3vp4W7luK","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Om Maya","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/om-maya","logokey":"$0XWTS0R0QszExCr7Z6udxAz3F7y4Bou52IMWzBE8fD8mPugReWxWAD","tagline":null,"urlname":"/investor_page/om-maya","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMLq_pUJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FfLdrFYt9b3UCG6EvCluVYNBu77JA2gyQdMep6dWw2MU5uzUylpVcR","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0XWTS0R0QszExCr7Z6udxAz3F7y4Bou52IMWzBE8fD8mPugReWxWAD","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"X1SfxgWmaR8siuSCjJt6VrlTf6yT6s7KUVByVAev2s01Goo0Whv6M7","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Katao Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/katao-venture-partners","logokey":"$AaJCBQEbJFoXpyPdZU9ZGkYjIrokm95VviLXPHw2WwOOtIJjGC62bq","tagline":null,"urlname":"/investor_page/katao-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMiGtJ4JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ZUnivMwdeWmNFNw4Cwf58ZLwDX2HWjQv5L6G8ky3bvk0cCP8xyEYPW","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AaJCBQEbJFoXpyPdZU9ZGkYjIrokm95VviLXPHw2WwOOtIJjGC62bq","leadcaption":"","followupcaption":""},{"name":"NextLeap Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nextleap-ventures","logokey":"$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","tagline":null,"urlname":"/investor_page/nextleap-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJH0vM0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"vGhC0qqH8k7kw16ZIIvhTpGlqaCSMH8A3j4UfG3KhBGhzQx5XDorwc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCsqZOICww","date":"Aug 2020","amount":"$500K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"2fb9e915-b04a-4c6e-b648-1ed7697a4311","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCh3azeCgw","date":"Jul 2020","amount":"$500K","source":"Gideon the CEO","eventtype":"FundingRoundEvent","investment":[{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8c1d5eff-13f1-4d31-be85-5ce65e2426a3","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Private","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"W2MshKAX6HIMQttcLJjUJ9li0zzLpUNSNNnoSFKu1kmQMaJainbgmD","hub":"EIT Food Accelerator Network","date":"Jun 2020","batch":"# 3","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4KjTtNgLDA","source":"https://digioh.s3.amazonaws.com/vendors/vendor_28730/em_files/em_file_175182/EITFAN2020PRcohort.pdf?AWSAccessKeyId=AKIAJ23IM33EG3FDC6XQ&Expires=1673953141&Signature=Y7%2FFINqvcJ0XBwIXd0WfPn2hNqQ%3D","enddate":"Oct 2020","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":false,"investment":[],"hub_fullurl":"/program_page/eit-food-accelerator-network","hub_logokey":"$lSLKqTdAgFSHRVTvNUYZyVHbJBVciPnjdDzBRlProaDLdZEW5POKmz","hub_urlname":"/program_page/eit-food-accelerator-network","eventvisibility":null,"amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$lSLKqTdAgFSHRVTvNUYZyVHbJBVciPnjdDzBRlProaDLdZEW5POKmz","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODBpImfCgw","hub":"MassChallenge","date":"Mar 2020","batch":"5","amount":"Undisclosed","hub_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODkntSkCQw","source":"https://masschallenge.org/announcement/masschallenge-israel-announces-startups-for-2020-accelerator;https://www.geektime.co.il/openning-the-fifth-cycle-of-masschalange-accelerator/","enddate":"","hub_type":"Accelerator","eventtype":"GraduationEvent","hub_hidden":true,"investment":[],"hub_fullurl":"/program_page/masschallenge","hub_logokey":"$xeIZnlxhlTMaDEUMppRcRk0v1Nbv5bTJ3x8lVrQeyJjrrNdrddk7gp","hub_urlname":"/program_page/masschallenge","eventvisibility":"Public","amountvisibility":null,"fundingvisibility":null,"style":"","hiddenCompanyTooltip":"","hub_logourl":"https://storage.googleapis.com/clean-finder-353810/$xeIZnlxhlTMaDEUMppRcRk0v1Nbv5bTJ3x8lVrQeyJjrrNdrddk7gp","amountnumber":null,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"6/2020","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Enzymit","logourl":"https://storage.googleapis.com/clean-finder-353810/$6nkn9KpSVAMuDR8HUXMrrkaR177G6XY4GXJ3YxYoGK672oMcsAJMPc","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$6nkn9KpSVAMuDR8HUXMrrkaR177G6XY4GXJ3YxYoGK672oMcsAJMPc","seoabout":"Enzymit is a bioproduction platform company developing cell-free enzymatic manufacturing technology to make bioproduction faster, simpler, cost effective, ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":3,"primarySector":"Agriculture & Food Technologies","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Climate Tech","queryString":"sectorclassification=2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H","classificationName":"sectorclassification"},{"depth":2,"name":"Clean Industry Tech ","queryString":"sectorclassification=bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB","classificationName":"sectorclassification"},{"depth":3,"name":"Sustainable Materials & Circularity","queryString":"sectorclassification=pmOn9QejBmHE4v4ME8eer1Fgn94EqGjX7Pcq1pHOxTziTLZFvyYD6P","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Food Tech","queryString":"sectorclassification=v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","classificationName":"sectorclassification"},{"depth":3,"name":"Novel Food & Ingredients","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Deep Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDl6YLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Energy, Utilities & Waste Management","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"New Fuels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biofuels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvtsb8KDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Crops","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1usgLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H>Clean Industry Tech #bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB>Sustainable Materials & Circularity#pmOn9QejBmHE4v4ME8eer1Fgn94EqGjX7Pcq1pHOxTziTLZFvyYD6P","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","TechnologyClassificationModel>Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","TechnologyClassificationModel>Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp>Novel Food & Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","SectorClassificationModel>Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H","SectorClassificationModel>Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H>Clean Industry Tech #bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","IndustryClassificationModel>Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA>Deep Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDl6YLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","IndustryClassificationModel>Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA>New Fuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA>New Fuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA>Biofuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvtsb8KDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Crops#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1usgLDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA>Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H|2:>SectorClassificationModel>Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H/Clean Industry Tech #bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB|3:>SectorClassificationModel>Climate Tech#2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H>Clean Industry Tech #bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB/Sustainable Materials & Circularity#pmOn9QejBmHE4v4ME8eer1Fgn94EqGjX7Pcq1pHOxTziTLZFvyYD6P|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|1:>SectorClassificationModel/Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA|2:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA/Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp|3:>SectorClassificationModel>Agriculture & Food Technologies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA>Food Tech#v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp/Novel Food & Ingredients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|1:>TechnologyClassificationModel/Biologicals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA|1:>TechnologyClassificationModel/Platforms & Interfaces#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|2:>TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA/Deep Learning#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDl6YLDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Pharmaceuticals#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA|1:>IndustryClassificationModel/Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA|2:>IndustryClassificationModel>Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA/New Fuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA|3:>IndustryClassificationModel>Energy, Utilities & Waste Management#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA>New Fuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA/Biofuels#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvtsb8KDA|1:>IndustryClassificationModel/Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA|2:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA/Crops#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1usgLDA|2:>IndustryClassificationModel>Agriculture & Food#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA/Processed Foods#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA|","classificationTrees":{"sector":[{"title":"Climate Tech","key":"0-0","path":"SectorClassificationModel>Climate Tech","children":[{"title":"Clean Industry Tech ","key":"0-0-0","path":"SectorClassificationModel>Climate Tech>Clean Industry Tech ","children":[{"title":"Sustainable Materials & Circularity","key":"0-0-0-0","path":"SectorClassificationModel>Climate Tech>Clean Industry Tech >Sustainable Materials & Circularity"}]}]},{"title":"Health Tech & Life Sciences","key":"0-1","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-1-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"}]}]},{"title":"Agriculture & Food Technologies","key":"0-2","path":"SectorClassificationModel>Agriculture & Food Technologies","children":[{"title":"Food Tech","key":"0-2-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Food Tech","children":[{"title":"Novel Food & Ingredients","key":"0-2-0-0","path":"SectorClassificationModel>Agriculture & Food Technologies>Food Tech>Novel Food & Ingredients"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Pharmaceuticals","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Pharmaceuticals"}]}]},{"title":"Energy, Utilities & Waste Management","key":"0-1","path":"IndustryClassificationModel>Energy, Utilities & Waste Management","children":[{"title":"New Fuels","key":"0-1-0","path":"IndustryClassificationModel>Energy, Utilities & Waste Management>New Fuels","children":[{"title":"Biofuels","key":"0-1-0-0","path":"IndustryClassificationModel>Energy, Utilities & Waste Management>New Fuels>Biofuels"}]}]},{"title":"Agriculture & Food","key":"0-2","path":"IndustryClassificationModel>Agriculture & Food","children":[{"title":"Crops","key":"0-2-0","path":"IndustryClassificationModel>Agriculture & Food>Crops"},{"title":"Processed Foods","key":"0-2-1","path":"IndustryClassificationModel>Agriculture & Food>Processed Foods"}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances"},{"title":"Biologicals","key":"0-1","path":"TechnologyClassificationModel>Biologicals"},{"title":"Platforms & Interfaces","key":"0-2","path":"TechnologyClassificationModel>Platforms & Interfaces"},{"title":"Artificial Intelligence","key":"0-3","path":"TechnologyClassificationModel>Artificial Intelligence","children":[{"title":"Deep Learning","key":"0-3-0","path":"TechnologyClassificationModel>Artificial Intelligence>Deep Learning"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Climate Tech","queryString":"sectorclassification=2XlxgkgJqQDOIfhs3EVUR3f1CSBfH5EbGpbqaDIOzhzse8M7Y05V4H","classificationName":"sectorclassification"},{"depth":2,"name":"Clean Industry Tech ","queryString":"sectorclassification=bvM6wAikSv5GbT1rZcmu1efHra6ppRHuyNnnvUF8aQX8n79xnxJ1UB","classificationName":"sectorclassification"},{"depth":3,"name":"Sustainable Materials & Circularity","queryString":"sectorclassification=pmOn9QejBmHE4v4ME8eer1Fgn94EqGjX7Pcq1pHOxTziTLZFvyYD6P","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":1,"name":"Agriculture & Food Technologies","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Jvz2KAJDA","classificationName":"sectorclassification"},{"depth":2,"name":"Food Tech","queryString":"sectorclassification=v1kI0kRGQPJEvgbgbBqvmhMA1uJyL8xRnPzuj1npR0zDVQ9AcpWQBp","classificationName":"sectorclassification"},{"depth":3,"name":"Novel Food & Ingredients","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuayfwJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":1,"name":"Biologicals","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Ie8rfEJDA","classificationName":"coretechnology"},{"depth":1,"name":"Platforms & Interfaces","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxioUJDA","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":2,"name":"Deep Learning","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuDl6YLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Pharmaceuticals","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pZ8LDA","classificationName":"targetcustomer"},{"depth":1,"name":"Energy, Utilities & Waste Management","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1pe8LDA","classificationName":"targetcustomer"},{"depth":2,"name":"New Fuels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IedsPgLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biofuels","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lvtsb8KDA","classificationName":"targetcustomer"},{"depth":1,"name":"Agriculture & Food","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8vYIDA","classificationName":"targetcustomer"},{"depth":2,"name":"Crops","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1usgLDA","classificationName":"targetcustomer"},{"depth":2,"name":"Processed Foods","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18OgKDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Climate Tech","Clean Industry Tech ","Sustainable Materials & Circularity","Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering","Agriculture & Food Technologies","Food Tech","Novel Food & Ingredients"],"coreTechnology":["Materials & Substances","Biologicals","Platforms & Interfaces","Artificial Intelligence","Deep Learning"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Pharmaceuticals","Energy, Utilities & Waste Management","New Fuels","Biofuels","Agriculture & Food","Crops","Processed Foods"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"block","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"Nq69WHzwAQF0pvdmfoMx8DBsgdQOAphSObuytSEMpm1qENy9vTuqFi","date":"Sep 2024","amount":"$10M","source":"https://www.calcalistech.com/ctechnews/article/b1k3mjxrr //https://www.divedigital.de/projects/, PB","eventtype":"FundingRoundEvent","investment":[{"name":"Khosla Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"d7jYNinoQTmjVGth3sW0jyrejGhDeW8xNtIL3kcnBpCWBKzUcmN7zF","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Grove Ventures","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/grove-ventures","logokey":"$n4AHC9JNL8UoAR7yguMpBlRFWXOp9AkDTErvx7uuoQcLXJ1dRsa5nb","tagline":null,"urlname":"/investor_page/grove-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwLioiJYKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"kXQPrVNeigj3WyQq1FPc58cX53098h3x1ayM7B7OQwtohYq2meyG8U","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$n4AHC9JNL8UoAR7yguMpBlRFWXOp9AkDTErvx7uuoQcLXJ1dRsa5nb","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"First Star Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/first-star-ventures","logokey":null,"tagline":"","urlname":"/investor_page/first-star-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJD04szaCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"LEyutPLnD9efJADBV7CXk2avlxTuBOl9aZJM1T7rFPUU0aRQRXqulF","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Sapir Venture Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"q5I6SRLXeprnogtgbLhjvN2xvvRFlaGfO45THl42pjyVVVoRRL4V6t","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"DIVEdigital","type":"Investor","amount":null,"hidden":false,"country":"Germany","fullurl":"/investor_page/divedigital","logokey":"$YcNs5CAZ4k0qKPWbpYHUDkUsGkJ5sS35ElCQVDIAR2JmRA5AzUgYD7.png","tagline":"","urlname":"/investor_page/divedigital","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyP2jCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"xS1qnWHJex5myh4V8ruUXjx4YxzTS7PiyLxLHUTX6TVvUxlHipMSzX","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$YcNs5CAZ4k0qKPWbpYHUDkUsGkJ5sS35ElCQVDIAR2JmRA5AzUgYD7.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":10000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDMxP_dCww","date":"Jan 2022","amount":"$5.5M","source":"https://www.einnews.com/pr_news/567725114/enzymit-inc-successfully-closes-5-million-seed-round-to-transform-the-global-chemical-market","eventtype":"FundingRoundEvent","investment":[{"name":"First Star Ventures","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/first-star-ventures","logokey":null,"tagline":"","urlname":"/investor_page/first-star-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJD04szaCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"YbjJ3TjDmxBhPHCjMkP2tj8E0W1B3veVKTa8OtU1trFJi3vp4W7luK","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"Lead&nbsp;","followupcaption":""},{"name":"Om Maya","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/om-maya","logokey":"$0XWTS0R0QszExCr7Z6udxAz3F7y4Bou52IMWzBE8fD8mPugReWxWAD","tagline":null,"urlname":"/investor_page/om-maya","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMLq_pUJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"FfLdrFYt9b3UCG6EvCluVYNBu77JA2gyQdMep6dWw2MU5uzUylpVcR","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0XWTS0R0QszExCr7Z6udxAz3F7y4Bou52IMWzBE8fD8mPugReWxWAD","leadcaption":"","followupcaption":""},{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"X1SfxgWmaR8siuSCjJt6VrlTf6yT6s7KUVByVAev2s01Goo0Whv6M7","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Katao Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/katao-venture-partners","logokey":"$AaJCBQEbJFoXpyPdZU9ZGkYjIrokm95VviLXPHw2WwOOtIJjGC62bq","tagline":null,"urlname":"/investor_page/katao-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMiGtJ4JDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ZUnivMwdeWmNFNw4Cwf58ZLwDX2HWjQv5L6G8ky3bvk0cCP8xyEYPW","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$AaJCBQEbJFoXpyPdZU9ZGkYjIrokm95VviLXPHw2WwOOtIJjGC62bq","leadcaption":"","followupcaption":""},{"name":"NextLeap Ventures","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/nextleap-ventures","logokey":"$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","tagline":null,"urlname":"/investor_page/nextleap-ventures","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJH0vM0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"vGhC0qqH8k7kw16ZIIvhTpGlqaCSMH8A3j4UfG3KhBGhzQx5XDorwc","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":null,"leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$rG771X7Dz0RRsVF3Y3H1i2ZDx3LB91f4JFROpA59Xzm7gtM8Ff3yfJ","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCh3azeCgw","date":"Jul 2020","amount":"$500K","source":"Gideon the CEO","eventtype":"FundingRoundEvent","investment":[{"name":"Sapir Venture Partners","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/sapir-venture-partners","logokey":"$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","tagline":null,"urlname":"/investor_page/sapir-venture-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoK3Uh4gKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8c1d5eff-13f1-4d31-be85-5ce65e2426a3","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Private","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hnSVpDJeZID0aUOdXXCR79yhWHaeftNMBORWJSBBD8exnkfalbM5cy","leadcaption":"Lead&nbsp;","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Private","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[{"id":"RvQn6HQjEHYBIOIoomjVeFa165iHExqX3FPvt0U4R8IcjxKGSBmsjw","date":"Nov 2022","amount":"$500K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCsqZOICww","date":"Aug 2020","amount":"$500K","source":"","eventtype":"GrantEvent","granttype":1,"investment":[{"name":null,"type":null,"amount":0,"hidden":false,"country":"Israel","fullurl":null,"logokey":null,"tagline":null,"urlname":null,"isisraeli":null,"investorid":null,"fundingtype":"Angel","leadpartner":null,"investmentid":"2fb9e915-b04a-4c6e-b648-1ed7697a4311","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":null,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/empty-state.svg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":null,"isjointventuregrant":0,"fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Non-Equity Funding","isgrant":true,"isicoevent":false,"amountnumber":500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"merger_acquisitions":[],"others":[]}}